The Global Immunohistochemistry Market Size accounted for USD 3.1 Billion in 2023 and is estimated to achieve a market size of USD 5.9 Billion by 2032 growing at a CAGR of 7.6% from 2024 to 2032.
Immunohistochemistry Market Highlights
- Global immunohistochemistry market revenue is poised to garner USD 5.9 billion by 2032 with a CAGR of 7.6% from 2024 to 2032
- North America immunohistochemistry market value occupied around USD 1.2 billion in 2023
- Asia-Pacific immunohistochemistry market growth will record a CAGR of more than 8.3% from 2024 to 2032
- Among application, the diagnostics sub-segment generated more than USD 2.1 billion revenue in 2023
- Based on end-use, the hospitals and diagnostic Laboratories sub-segment generated around 71% immunohistochemistry market share in 2023
- Growing research activities in immuno-oncology is a popular immunohistochemistry market trend that fuels the industry demand
Immunohistochemistry (IHC) is a technique used in biology and medicine to identify and locate specific proteins within tissue slices. It combines immunological and histological methods to detect antigens by labeling antibodies with a visible marker, such as a dye or a fluorescent molecule. When these tagged antibodies bind to their target antigen, they emit a colorful or fluorescent signal that may be seen with a microscope. IHC is commonly used to diagnose diseases, such as cancer, by recognizing specific cellular markers that signal disease presence or type. It also supports research by exposing protein distribution and localization within tissues, allowing for better understanding of cellular processes and disease mechanisms.
Global Immunohistochemistry Market Dynamics
Market Drivers
- Growing prevalence of chronic diseases like cancer
- Advancements in diagnostic technologies
- Increasing demand for personalized medicine
- Rising healthcare expenditure globally
Market Restraints
- High costs of immunohistochemistry equipment
- Lack of skilled professionals in developing regions
- Stringent regulatory requirements
Market Opportunities
- Expansion in emerging markets
- Development of novel biomarkers
- Integration with digital pathology
Immunohistochemistry Market Report Coverage
| Market |
Immunohistochemistry Market
|
| Immunohistochemistry Market Size 2022 |
USD 3.1 Billion
|
| Immunohistochemistry Market Forecast 2032 |
USD 5.9 Billion |
| Immunohistochemistry Market CAGR During 2023 - 2032 |
7.6% |
| Immunohistochemistry Market Analysis Period |
2020 - 2032 |
Immunohistochemistry Market Base Year
|
2022 |
| Immunohistochemistry Market Forecast Data |
2023 - 2032 |
| Segments Covered |
By Product, By Application, By End-Use, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Danaher Corporation, Agilent Technologies, Inc., Bio SB, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Abcam plc, Cell Signaling Technology, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Immunohistochemistry Market Insights
Immunohistochemistry (IHC) is a critical technique that uses monoclonal and polyclonal antibodies to detect and visualize antigen distribution in tissue samples. This approach is widely used in illness diagnosis, particularly cancer, because it detects the presence of tumor antigens, which aids in discriminating between benign and malignant tumors. The increased frequency of chronic diseases, combined with a rapidly aging population, are important drivers of the IHC market. Cancer incidence is increasing internationally, which is predicted to increase demand for effective diagnostic techniques such as IHC. This approach is important in illness diagnosis since it can predict tumor prognosis as well as identify enzymes, tumor suppressor genes, antigens, and tumor cell proliferation. Furthermore, IHC is useful in identifying specific cellular markers that can guide targeted therapy, making it a crucial tool in personalized medicine.
Antibody technology developments, which enable for more precise and reliable antigen detection, are also driving market expansion. Furthermore, the combination of IHC with digital pathology and image processing techniques improves diagnostic accuracy and efficiency. However, the market confronts constraints like as high IHC equipment prices and the demand for experienced personnel to interpret data. Nonetheless, there are potential for market expansion, especially in emerging nations with rapidly increasing healthcare infrastructure. The ongoing development of novel biomarkers, as well as the increased emphasis on immuno-oncology research, are projected to propel the immunohistochemistry market ahead.
Immunohistochemistry Market Segmentation
The worldwide market for immunohistochemistry is split based on product, application, end-use, and geography.
Immunohistochemistry Products
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
According to immunohistochemistry industry analysis, the antibodies section earns the most income due to their vital function in the diagnostic process. Antibodies, both monoclonal and polyclonal, are required to recognize specific antigens inside tissue samples, which is the foundation of immunohistochemistry. They enable the exact identification of proteins, enzymes, and other biological indicators, making them critical in illness diagnosis, particularly in cancer. The increased desire for personalized treatment and targeted therapy increases the need for particular antibodies. Furthermore, advances in antibody production technology have increased their specificity and reliability, resulting in widespread adoption. As a result, the antibodies sector remains the most profitable in the IHC market, owing to its critical role in diagnostic and research.
Immunohistochemistry Applications
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
The diagnostics segment dominates the immunohistochemistry (IHC) market, owing to its broad use in disease detection, notably cancer. IHC's capacity to detect the presence of specific antigens in tissue samples makes it an essential tool for diagnosing illnesses at the molecular level. This precision is crucial for distinguishing between different types of cancers and determining their stage, which has a direct impact on treatment options. The increased frequency of chronic diseases such as cancer, combined with the need for early and precise detection, drives the diagnostics segment. Furthermore, combining IHC with modern imaging techniques improves diagnosis accuracy, further establishing its market leadership.
Immunohistochemistry End-Uses
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
Hospitals and diagnostic laboratories are the primary end-users in the immunohistochemistry market due to their critical role in frontline healthcare and diagnostics. These institutions rely on IHC to accurately identify a wide range of disorders, particularly cancer, where the identification of specific biomarkers is critical for determining optimal treatment regimens. The huge volume of patients treated in hospitals and labs necessitates the frequent use of IHC, which ensures quick and accurate diagnostic results. Furthermore, the increased emphasis on customized treatment has highlighted the significance of IHC in clinical decision-making in these settings. As a result of their essential role in patient care and diagnostic innovation, hospitals and diagnostic laboratories dominate the market.
Immunohistochemistry Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Immunohistochemistry Market Regional Analysis
Asia-Pacific is evaluated to observe the quickest development over the immunohistochemistry market forecast period attributable to rising disposable income, high neglected clinical requirements of patients, rising mindfulness about early finding, and accessibility of successful treatment in rising nations, for example, India and China. Asia-Pacific is the most encouraging goal for market players because of expanding instances of different sorts of cancers growths in this region. North America was at the front line of the immunohistochemistry market, with an offer of about 38.0% in 2023. Governments in the particular region are empowering continuous research exercises on immunohistochemistry (IHC) by financing them.
Immunohistochemistry Market Players
Some of the top immunohistochemistry companies offered in our report include Danaher Corporation, Agilent Technologies, Inc., Bio SB, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Abcam plc, Cell Signaling Technology, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.
CHAPTER 1. Industry Overview of Immunohistochemistry Market
1.1. Definition and Scope
1.1.1. Definition of Immunohistochemistry
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Immunohistochemistry Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Immunohistochemistry Market By Product
1.2.3. Immunohistochemistry Market By Application
1.2.4. Immunohistochemistry Market By End-Use
1.2.5. Immunohistochemistry Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Immunohistochemistry Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Immunohistochemistry Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Immunohistochemistry Market By Product
5.1. Introduction
5.2. Immunohistochemistry Revenue By Product
5.2.1. Immunohistochemistry Revenue (USD Million) and Forecast, By Product, 2020-2032
5.2.2. Antibodies
5.2.2.1. Antibodies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. Primary Antibodies
5.2.2.2.1. Primary Antibodies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. Secondary Antibodies
5.2.2.3.1. Secondary Antibodies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Equipment
5.2.3.1. Equipment Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.2. Slide Staining Systems
5.2.3.2.1. Slide Staining Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.3. Tissue Microarrays
5.2.3.3.1. Tissue Microarrays Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.4. Tissue Processing Systems
5.2.3.4.1. Tissue Processing Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.5. Slide Scanners
5.2.3.5.1. Slide Scanners Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.6. Others
5.2.3.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Reagents
5.2.4.1. Reagents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.2. Histological Stains
5.2.4.2.1. Histological Stains Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.3. Blocking Sera and Reagents
5.2.4.3.1. Blocking Sera and Reagents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.4. Chromogenic Substrates
5.2.4.4.1. Chromogenic Substrates Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.5. Fixation Reagents
5.2.4.5.1. Fixation Reagents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.6. Stabilizers
5.2.4.6.1. Stabilizers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.7. Organic Solvents
5.2.4.7.1. Organic Solvents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.8. Proteolytic Enzymes
5.2.4.8.1. Proteolytic Enzymes Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.9. Diluents
5.2.4.9.1. Diluents Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Kits
5.2.5.1. Kits Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Immunohistochemistry Market By Application
6.1. Introduction
6.2. Immunohistochemistry Revenue By Application
6.2.1. Immunohistochemistry Revenue (USD Million) and Forecast, By Application, 2020-2032
6.2.2. Diagnostics
6.2.2.1. Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.2. Cancer
6.2.2.2.1. Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.3. Infectious Diseases
6.2.2.3.1. Infectious Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.4. Cardiovascular Diseases
6.2.2.4.1. Cardiovascular Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.5. Autoimmune Diseases
6.2.2.5.1. Autoimmune Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.6. Diabetes Mellitus
6.2.2.6.1. Diabetes Mellitus Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.7. Nephrological Diseases
6.2.2.7.1. Nephrological Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Drug Testing
6.2.3.1. Drug Testing Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Immunohistochemistry Market By End-Use
7.1. Introduction
7.2. Immunohistochemistry Revenue By End-Use
7.2.1. Immunohistochemistry Revenue (USD Million) and Forecast, By End-Use, 2020-2032
7.2.2. Hospitals and Diagnostic Laboratories
7.2.2.1. Hospitals and Diagnostic Laboratories Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Research Institutes
7.2.3.1. Research Institutes Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Immunohistochemistry Market By Country
8.1. North America Immunohistochemistry Market Overview
8.2. U.S.
8.2.1. U.S. Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
8.2.2. U.S. Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
8.2.3. U.S. Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.3. Canada
8.3.1. Canada Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
8.3.2. Canada Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
8.3.3. Canada Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Immunohistochemistry Market By Country
9.1. Europe Immunohistochemistry Market Overview
9.2. U.K.
9.2.1. U.K. Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
9.2.2. U.K. Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.3. U.K. Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.3. Germany
9.3.1. Germany Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
9.3.2. Germany Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.3. Germany Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.4. France
9.4.1. France Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
9.4.2. France Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
9.4.3. France Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.5. Spain
9.5.1. Spain Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
9.5.2. Spain Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
9.5.3. Spain Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
9.6.2. Rest of Europe Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Immunohistochemistry Market By Country
10.1. Asia Pacific Immunohistochemistry Market Overview
10.2. China
10.2.1. China Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
10.2.2. China Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.3. China Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.3. Japan
10.3.1. Japan Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
10.3.2. Japan Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.3. Japan Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.4. India
10.4.1. India Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
10.4.2. India Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.3. India Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.5. Australia
10.5.1. Australia Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
10.5.2. Australia Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
10.5.3. Australia Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.6. South Korea
10.6.1. South Korea Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
10.6.2. South Korea Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
10.6.3. South Korea Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
10.7.2. Rest of Asia-Pacific Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Immunohistochemistry Market By Country
11.1. Latin America Immunohistochemistry Market Overview
11.2. Brazil
11.2.1. Brazil Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.2. Brazil Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.3. Brazil Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
11.3. Mexico
11.3.1. Mexico Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.2. Mexico Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.3. Mexico Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
11.4.2. Rest of Latin America Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Immunohistochemistry Market By Country
12.1. Middle East & Africa Immunohistochemistry Market Overview
12.2. GCC
12.2.1. GCC Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
12.2.2. GCC Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.3. GCC Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
12.3. South Africa
12.3.1. South Africa Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
12.3.2. South Africa Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.3. South Africa Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Immunohistochemistry Revenue (USD Million) and Forecast By Product, 2020-2032
12.4.2. Rest of Middle East & Africa Immunohistochemistry Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Immunohistochemistry Revenue (USD Million) and Forecast By End-Use, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Immunohistochemistry Market
13.1. Immunohistochemistry Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Immunohistochemistry Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Danaher Corporation
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. Danaher Corporation 2023 Immunohistochemistry Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Agilent Technologies, Inc.
14.3. Bio SB
14.4. PerkinElmer, Inc.
14.5. Bio-Rad Laboratories, Inc.
14.6. Merck KGaA
14.7. Abcam plc
14.8. Cell Signaling Technology, Inc.
14.9. F. Hoffmann-La Roche Ltd.
14.10. Thermo Fisher Scientific Inc.
